'E-CANCER' by Mike Parker - Sick or Treat Sessions

10
eCancer: Licensing Software Mike Parker October 2015

Transcript of 'E-CANCER' by Mike Parker - Sick or Treat Sessions

Page 1: 'E-CANCER' by Mike Parker - Sick or Treat Sessions

eCancer: Licensing Software IP

Mike

Par

ker

Octo

ber 2

015

Page 2: 'E-CANCER' by Mike Parker - Sick or Treat Sessions

Agenda1. Product Attributes2. Product Initiatives3. Evolution of Software

Licensing4. Moving up the value chain5. If Drugs Were Software6. Emerging Licensing Trends

Page 3: 'E-CANCER' by Mike Parker - Sick or Treat Sessions

Product Attributes

High Up-Front Research Costs

Iterative Development

ProcessLow Distribution

Costs High Piracy Risk

Look Familiar?

Page 4: 'E-CANCER' by Mike Parker - Sick or Treat Sessions

Research Labs

Customer Research

Market Trends

Research laboratories developing point solutions with no immediate use

Asking customers what they want

Identifying future requirements to stay ahead of the game

Product Initiatives

Page 5: 'E-CANCER' by Mike Parker - Sick or Treat Sessions

The Market Dichotomy

Unknown Needs

Customer Requests

Page 6: 'E-CANCER' by Mike Parker - Sick or Treat Sessions

Retail/FPP

Multi-Licence

Pack

Volume Licensin

gSite

Licence

Activation

Evolution of Software Licensing

Page 7: 'E-CANCER' by Mike Parker - Sick or Treat Sessions

Moving up the value chain

Page 8: 'E-CANCER' by Mike Parker - Sick or Treat Sessions

If Drugs Were SoftwareTarget Customers

Requirements

Discrete Licensing Volume Licensing

Page 9: 'E-CANCER' by Mike Parker - Sick or Treat Sessions

Emerging Licensing Models Monthly/Annual Subscriptions

Ad-Supported

Freemium

Value Sharing

Page 10: 'E-CANCER' by Mike Parker - Sick or Treat Sessions

Thank you